Serum 25-hydroxyvitamin D is associated with incident peripheral artery disease among white and black adults in the ARIC study cohort

Atherosclerosis

Volumn 257, Issue , 2017, Pages 123-129

  Rapson, Ian R ^a   Michos, Erin D ^b   Alonso, Alvaro ^c   Hirsch, Alan T ^a   Matsushita, Kunihiro ^b   Reis, Jared P ^d   Lutsey, Pamela L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

ARIC; Cohort study; Epidemiology; Peripheral arterial disease; Race; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; CALCIUM; CREATININE; CYSTATIN C; FIBROBLAST GROWTH FACTOR 23; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D; VITAMIN D BINDING PROTEIN; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER;

ADULT; AFRICAN AMERICAN; ARTICLE; BODY MASS; CALCIUM BLOOD LEVEL; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; EUROPEAN AMERICAN; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; INTERMITTENT CLAUDICATION; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PARATHYROID HORMONE BLOOD LEVEL; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHOSPHATE BLOOD LEVEL; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; SUN EXPOSURE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BLOOD; CAUCASIAN; CLINICAL TRIAL; EPIDEMIOLOGY; ETHNOLOGY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PERIPHERAL ARTERIAL DISEASE; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR; UNITED STATES;

AFRICAN AMERICANS; BIOMARKERS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIPHERAL ARTERIAL DISEASE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UNITED STATES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 85010379978     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2017.01.016     Document Type: Article

References (45)

1. [1] Go, A.S., et al. Heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation 129:3 (2014), e28–e292.
2. [2] Allison, M.A., et al. Ethnic-specific prevalence of peripheral arterial disease in the United States. Am. J. Prev. Med. 32:4 (2007), 328–333.
3. [3] Ostchega, Y., et al. Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999-2004. J. Am. Geriatr. Soc. 55:4 (2007), 583–589.
4. [4] Ankle Brachial Index Collaboration. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 300:2 (2008), 197–208.
5. [5] Criqui, M.H., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N. Engl. J. Med. 326:6 (1992), 381–386.
6. [6] Holick, M.F., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96:7 (2011), 1911–1930.
7. [7] Gutierrez, O.M., et al. Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey. Osteoporos. Int. 22:6 (2011), 1745–1753.
8. [8] Ford, J.A., et al. Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis. Am. J. Clin. Nutr. 100:3 (2014), 746–755.
9. [9] Wang, L., et al. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ. Cardiovasc Qual. Outcomes 5:6 (2012), 819–829.
10. [10] Chowdhury, R., et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ, 348, 2014 p. g1903.
11. [11] Michos, E.D., et al. 25-hydroxyvitamin D levels, vitamin D binding protein gene polymorphisms and incident coronary heart disease among whites and blacks: the ARIC study. Atherosclerosis 241:1 (2015), 12–17.
12. [12] Lutsey, P.L., et al. Race and vitamin D binding protein gene polymorphisms modify the association of 25-hydroxyvitamin D and incident heart failure: the ARIC (atherosclerosis risk in Communities) study. JACC Heart Fail 3:5 (2015), 347–356.
13. [13] Robinson-Cohen, C., et al. Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events. JAMA 310:2 (2013), 179–188.
14. [14] Michos, E.D., et al. 25-Hydroxyvitamin D deficiency is associated with fatal stroke among whites but not blacks: the NHANES-III linked mortality files. Nutrition 28:4 (2012), 367–371.
15. [15] Kunutsor, S.K., Apekey, T.A., Steur, M., Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants. Eur. J. Epidemiol. 28:3 (2013), 205–221.
16. [16] Witham, M.D., Nadir, M.A., Struthers, A.D., Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J. Hypertens. 27:10 (2009), 1948–1954.
17. [17] Vimaleswaran, K.S., et al. Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study. Lancet Diabetes Endocrinol. 2:9 (2014), 719–729.
18. [18] Li, Y.C., Vitamin D regulation of the renin-angiotensin system. J. Cell Biochem. 88:2 (2003), 327–331.
19. [19] Xiang, W., et al. Cardiac Hypertrophy in Vitamin D Receptor Knockout Mice: Role of the Systemic and Cardiac Renin-angiotensin Systems, vol. 288, 2005, E125–E132.
20. [20] Vaidya, A., Forman, J.P., Vitamin D and hypertension: current evidence and future directions. Hypertension 56:5 (2010), 774–779.
21. [21] Boucher, B.J., Inadequate vitamin D status: does it contribute to the disorders comprising syndrome ‘X’?. British Journal of Nutrition, 79(04), 2007, 315.
22. [22] Palomer, X., et al. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes. Obes. Metabolism 10:3 (2008), 185–197.
23. [23] Borissova, A.M., et al. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int. J. Clin. Pract. 57:4 (2003), 258–261.
24. [24] Pittas, A.G., et al. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 92:6 (2007), 2017–2029.
25. [25] Bikle, D.D., Vitamin D regulation of immune function. Vitam. Horm. 86 (2011), 1–21.
26. [26] Zittermann, A., Vitamin D and disease prevention with special reference to cardiovascular disease. Prog. Biophys. Mol. Biol. 92:1 (2006), 39–48.
27. [27] Martín-Ventura, J.L., et al. Possible role of parathyroid hormone–related protein as a proinflammatory cytokine in atherosclerosis. Stroke 34:7 (2003), 1783–1789.
28. [28] Somjen, D., et al. 25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 111:13 (2005), 1666–1671.
29. [29] Rigby, W.F., Denome, S., Fanger, M.W., Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J. Clin. Invest. 79:6 (1987), 1659–1664.
30. [30] Michos, E.D., Blumenthal, R.S., Vitamin D supplementation and cardiovascular disease risk. Circulation 115:7 (2007), 827–828.
31. [31] Schleithoff, S.S., et al. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am. J. Clin. Nutr. 83:4 (2006), 754–759.
32. [32] Melamed, M.L., et al. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler. Thromb. Vasc. Biol. 28:6 (2008), 1179–1185.
33. [33] Reis, J.P., et al. Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease. Am. J. Clin. Nutr. 88:6 (2008), 1469–1477.
34. [34] Anderson, J.L., et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am. J. Cardiol. 106:7 (2010), 963–968.
35. [35] Investigators, T.A., The atherosclerosis risk in community (aric) study: design and objectives. Am. J. Epidemiol. 129:4 (1989), 687–702.
36. [36] Lutsey, P.L., et al. The 25-hydroxyvitamin D3 C-3 epimer: distribution, correlates, and reclassification of 25-hydroxyvitamin D status in the population-based Atherosclerosis Risk in Communities Study (ARIC). Clin. Chim. Acta 442 (2015), 75–81.
37. [37] Wattanakit, K., et al. Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study. J. Am. Soc. Nephrol. 18:2 (2007), 629–636.
38. [38] Weatherley, B.D., et al. The reliability of the ankle-brachial index in the atherosclerosis risk in Communities (ARIC) study and the NHLBI family heart study (FHS). BMC Cardiovasc Disord., 6, 2006, 7.
39. [39] Baecke, J.A., Burema, J., Frijters, J.E., A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am. J. Clin. Nutr. 36:5 (1982), 936–942.
40. [40] National Heart, Lung, and Blood Institute, The ARIC Manuals of Operation Version 2.0. 1991, University of North Carolina Chapel Hill.
41. [41] Inker, L.A., et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N. Engl. J. Med. 367:1 (2012), 20–29.
42. [42] Pennisi, P., et al. Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. Osteoporos. Int. 15:5 (2004), 389–395.
43. [43] Fiore, C.E., et al. Association of high alpha2-Heremans-Schmid glycoprotein/fetuin concentration in serum and intima-media thickness in patients with atherosclerotic vascular disease and low bone mass. Atherosclerosis 195:1 (2007), 110–115.
44. [44] LeFevre, M.L., U.S.P.S.T, Force, screening for vitamin D deficiency in adults: U.S. Preventive services task force recommendation statement. Ann. Intern Med. 162:2 (2015), 133–140.
45. [45] Chun, R.F., et al. Vitamin D and DBP: the free hormone hypothesis revisited. J. Steroid Biochem. Mol. Biol., 2014, 132–137 144 Pt A.